Answers are grounded in this paper and cite their sources.
As reported before, the treatment of platelets with all currently known platelet aggregating agents was resulted in the reduction of nitric oxide (NO) synthesis through the inhibition of enzyme nitric oxide synthase (NOS). This reduction of NO in consequence released arachidonic acid from the platelet membrane ultimately leading to the aggregation of platelets.
No takes yet. Share an insight, caveat, or question.
D. Banerjee (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: